NIH-funded research R01 grant

Creating new amino acids using advanced biocatalysis techniques

Official title: Pyridoxal Radical Biocatalysis for the Stereoselective Production of Non-Canonical Amino Acids

Funded at University of California Santa Barbara · NIH-11133444 · Data updated 2026-11-12

This study is exploring new ways to make special building blocks called amino acids that can help create better medicines, using light and natural processes, so that patients can benefit from improved treatments.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Santa Barbara
NIH-funded
Lab location1 site (Santa Barbara, United States)
Project startApril 10, 2025
Project endMarch 31, 2029
Funding year2025
Award (this year)$553,775
NIH project number1R01EB036084-01A1
Project IDNIH-11133444 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would include individuals with conditions that could be treated with novel therapeutics derived from non-canonical amino acids.

Less likely to help

Patients who are not affected by conditions that could be treated with these new medications may not receive any benefit from this research.

What this research studies

This research focuses on developing innovative methods to produce non-canonical amino acids, which are important for creating new medicines and therapeutic proteins. By combining biocatalysis with photochemistry, the researchers aim to harness the power of enzymes in a novel way to create amino acids that are not typically found in nature. This approach involves using visible light to activate these enzymes, allowing for precise control over the chemical reactions that produce these valuable compounds. Patients may benefit from the resulting therapeutics that utilize these newly developed amino acids.

Why it matters

Potential benefit: If successful, this research could lead to the development of new and more effective medications tailored to specific health conditions.

How similar studies have gone: While biocatalysis has been explored in various contexts, this specific approach combining photochemistry and directed evolution for amino acid production is relatively novel and has not been extensively tested.

Where this research is happening

  • University of California Santa Barbara
    Santa Barbara, United States
    Active

Researchers

  • Principal investigator: Yang, Yang — University of California Santa Barbara
  • Study coordinator: Yang, Yang

Related research

Other NIH-funded projects on the same topics.

  • Understanding how PLP enzymes work and how to harness them

    Researchers at UC Santa Barbara are studying PLP-dependent enzymes to better understand their chemistry and how they can be used to make useful, complex molecules for medicines.

    NIH research University of California Santa Barbara · Santa Barbara, United States · NIH-11537706

  • Real-time molecular monitoring in the body with advanced sensors

    Aiming to measure drug and biomarker levels continuously inside the body using innovative sensors to support personalized, precise treatment.

    NIH research University of California Santa Barbara · Santa Barbara, United States · NIH-11448724

  • Molecular genetics of how Aedes mosquitoes taste and decide to bite

    Scientists are studying how the taste sense in Aedes aegypti mosquitoes works to help create better repellents that prevent bites.

    NIH research University of California Santa Barbara · Santa Barbara, United States · NIH-11447767

  • Enabling Imaging and Alpha Therapy with New Chelators for Cancer

    A cancer-focused project aims to create new chelators that let alpha-emitter radiopharmaceuticals both image and treat tumors more effectively.

    NIH research University of California Santa Barbara · Santa Barbara, United States · NIH-11427379

  • Personalized AI for Diverse Wearable Health Data

    Aging and diverse women’s health data from wearables will be used to create smarter, more accurate health insights through an AI system.

    NIH research University of California Santa Barbara · Santa Barbara, United States · NIH-11413547

  • CAR-M immunotherapy for cancer and beyond

    A cancer-fighting therapy using specially engineered macrophages (CAR-M) is being explored to work where current treatments struggle, with the aim of helping patients with various cancers and related conditions.

    NIH research University of California Santa Barbara · Santa Barbara, United States · NIH-11413445

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.